David Young, President & CEO, 10% Owner at Processa Pharmaceuticals, Inc. (PCSA), bought 60,000 shares at $0.52 ($29K) on 2023-04-11, disclosed to the SEC on 2023-04-13.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.52 | 20,000 | $10K | 35.9% |
| 2 | $0.45 | 20,000 | $9K | 31.0% |
| 3 | $0.48 | 20,000 | $10K | 33.1% |
| Total | $0.48 avg | 60,000 | $29K | 100% |
| Filing → |
| PCSA | BUY | 2026-06-01 | $5K | — | Filing → |
| PCSA | BUY | 2026-05-19 | $5K | — | Filing → |
| PCSA | BUY | 2026-05-01 | $5K | — | Filing → |